Abstract
The prevalence of age-related degenerative joint diseases, particularly intervertebral disc degeneration and osteoarthritis, is increasing, thereby posing significant challenges for the elderly population. Mitochondrial dysfunction is a critical factor in the etiology and progression of these disorders. Therapeutic interventions that incorporate mitochondrial transplantation exhibit considerable promise by increasing mitochondrial numbers and improving their functionality. Existing evidence suggests that exogenous mitochondrial therapy improves clinical outcomes for patients with degenerative joint diseases. This review elucidates the mitochondrial abnormalities associated with degenerative joint diseases and examines the mechanisms of mitochondrial intercellular transfer and artificial mitochondrial transplantation. Furthermore, therapeutic strategies for mitochondrial transplantation in degenerative joint diseases are synthesized, and the concept of engineered mitochondrial transplantation is proposed.
Funding Information
  • the Sichuan Province Centralized Guided Local Science and Technology Development Special Project (2023ZYD0072)
  • National Natural Science Foundation of China (82301785)
  • Doctoral research foundation of Affiliated Hospital of Putian University (2023KYDD001)
  • the Science and Technology Program of Luzhou City, Sichuan Province (2022SYF71)
  • Key research and development projects of Sichuan Science and Technology Plan Project (2024YFFK0135)

This publication has 116 references indexed in Scilit: